QuickView for NFE2L2;jsessionid=7691D4633560F05858B58D10A83DDD36 (gene)

1. NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export …
2. Clinical Implications of KEAP1-NFE2L2 Mutations in NSCLC.
3. Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
4. Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain.
5. KEAP1/NRF2 (NFE2L2) mutations in NSCLC - Fuel for a superresistant phenotype?

There were no clinical trials for NFE2L2;jsessionid=7691D4633560F05858B58D10A83DDD36